In BiomarkerBase we track biomarker use in trials, including those biomarkers used as patient selection criteria in particular clinical trials. We used this capability in a report we recently co-authored with BIO and Informa on clinical trials success rates (spoiler: patient selection biomarkers increase likelihood of approval significantly). For this chart of the week we use the same data to analyze the pipelines of the top pharma companies from our Personalized Medicine Scorecard to understand the how “covered” pharmaceutical companies are.
Ready to Improve Your Biomarker Intelligence?
[plsc_button url=”https://amplion.wpengine.com/contact/” target=”_blank” color=”green” style=”flat” radius=”square” size=”lg”]SCHEDULE A MEETING[/plsc_button]